Ursodeoxycholic Acid Suppresses Lipogenesis in Mouse Liver: Possible Role of the Decrease in β-Muricholic Acid, a Farnesoid X Receptor Antagonist
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ursodeoxycholic Acid Suppresses Lipogenesis in Mouse Liver: Possible Role of the Decrease in β-Muricholic Acid, a Farnesoid X Receptor Antagonist
Authors
Keywords
Sterol regulatory element-binding protein 1c, Cholesterol ester, Triglyceride, Fatty acid
Journal
LIPIDS
Volume 52, Issue 4, Pages 335-344
Publisher
Wiley
Online
2017-03-17
DOI
10.1007/s11745-017-4242-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ursodeoxycholic acid decreases age-related adiposity and inflammation in mice
- (2016) Ah-Reum Oh et al. BMB Reports
- Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity
- (2015) Michaela Mueller et al. JOURNAL OF HEPATOLOGY
- Cross-talk between bile acids and intestinal microbiota in host metabolism and health
- (2015) Yang-fan Nie et al. Journal of Zhejiang University-SCIENCE B
- Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction
- (2015) Changtao Jiang et al. Nature Communications
- Bile acid supplementation improves established liver steatosis in obese mice independently of glucagon-like peptide-1 secretion
- (2014) Pablo Quintero et al. JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY
- Dietary Hyodeoxycholic Acid Exerts Hypolipidemic Effects by Reducing Farnesoid X Receptor Antagonist Bile Acids in Mouse Enterohepatic Tissues
- (2014) Shiro Watanabe et al. LIPIDS
- Beyond intestinal soap—bile acids in metabolic control
- (2014) Folkert Kuipers et al. Nature Reviews Endocrinology
- Human FXR Regulates SHP Expression through Direct Binding to an LRH-1 Binding Site, Independent of an IR-1 and LRH-1
- (2014) Martijn O. Hoeke et al. PLoS One
- Ursodeoxycholic Acid Ameliorates Fructose-Induced Metabolic Syndrome in Rats
- (2014) Amr A. A. Mahmoud et al. PLoS One
- Gut Microbiota Regulates Bile Acid Metabolism by Reducing the Levels of Tauro-beta-muricholic Acid, a Naturally Occurring FXR Antagonist
- (2013) Sama I. Sayin et al. Cell Metabolism
- Ursodeoxycholic Acid Inhibits Liver X Receptor α-mediated Hepatic Lipogenesis via Induction of the Nuclear Corepressor SMILE
- (2013) Ji-Min Lee et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Muricholic bile acids are potent regulators of bile acid synthesis via a positive feedback mechanism
- (2013) X. Hu et al. JOURNAL OF INTERNAL MEDICINE
- Targeted profiling of circulating and hepatic bile acids in human, mouse, and rat using a UPLC-MRM-MS-validated method
- (2012) Juan C. García-Cañaveras et al. JOURNAL OF LIPID RESEARCH
- Ursodeoxycholic acid dose-dependently improves liver injury in rats fed a methionine- and choline-deficient diet
- (2011) Vyacheslav U. Buko et al. HEPATOLOGY RESEARCH
- Ursodeoxycholic acid improves insulin sensitivity and hepatic steatosis by inducing the excretion of hepatic lipids in high-fat diet–fed KK-Ay mice
- (2011) Takuma Tsuchida et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Overexpression of cholesterol 7α-hydroxylase promotes hepatic bile acid synthesis and secretion and maintains cholesterol homeostasis
- (2010) Tiangang Li et al. HEPATOLOGY
- Effects of farnesoid X receptor on the expression of the fatty acid synthetase and hepatic lipase
- (2010) Li-Li Shen et al. MOLECULAR BIOLOGY REPORTS
- Anti-Inflammatory and Proresolving Lipid Mediators
- (2008) Charles N. Serhan et al. Annual Review of Pathology-Mechanisms of Disease
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started